نتایج جستجو برای: cutaneous drug eruption

تعداد نتایج: 647476  

2016
Atiyah Patel Victor Mudenda Shabir Lakhi Owen Ngalamika

Sporotrichosis is a subacute or chronic granulomatous mycosis caused by fungus of the Sporothrix schenckii complex. It is considered to be a rare condition in most parts of the world. It mostly causes cutaneous infection but can also cause multisystemic disease. Unlike most deep cutaneous mycoses which have a primary pulmonary focus, it is usually caused by direct inoculation of the fungus into...

Journal: :Journal of investigational allergology & clinical immunology 2010
J L Cubero M M Garcés N Segura M T Sobrevía J Fraj A Lezaun C Colás

Acute generalized exanthematous pustulosis (AGEP) is characterized by acute onset of fever with a generalized erythematous pustular eruption. It seems that more than 90% of cases with AGEP are drug-induced [1]. The most frequently involved drugs are aminopenicillins, macrolides, antimycotic drugs, calcium channel blockers, carbamazepine, and paracetamol. We report a severe case of topical drug–...

2009
Mahkam Tavallaee Mahnaz Mahmoudi Rad

INTRODUCTION Fluconazole is a widely used antifungal agent with a possible side effect of fixed drug eruption. However, this adverse drug effect is absent from the reported list of possible side effects of fluconazole. We are presenting a rare case in our report. CASE PRESENTATION A 25-year-old Iranian woman developed fixed drug eruptions on different sites of her body after taking five doses...

Journal: :Actas dermo-sifiliograficas 2014
J Romaní L Leal A Sáez J Luelmo

3. Thirion L, Nikkels AF, Piérard GE. Etoricoxib-induced erythemamultiforme-like eruption. Dermatology. 2008;216:227--8. 4. Kreft B, Wohlrab J, Bramsiepe I, Eismann R, Winkler M, Marsch WC. Etoricoxib-induced toxic epidermal necrolysis: successful treatment with infliximab. J Dermatol. 2010;37:904--6. 5. Augustine M, Sharma P, Stephen J, Jayaseelan E. Fixed drug eruption and generalised erythem...

Journal: :Acta dermatovenerologica Croatica : ADC 2007
Claudia Cotena Paolo Gisondi Chiara Colato Giampiero Girolomoni

Cetuximab is a recombinant human/mouse chimeric monoclonal antibody that targets the extracellular domain of the epidermal growth factor receptor (EGFR). Cetuximab is approved by the US Food and Drug Administration for the treatment of EGFR-expressing metastatic colorectal cancer as monotherapy in patients who are intolerant to irinotecan-based chemotherapy, or in combination with irinotecan in...

Journal: :Dermatology 1994
A J Kanwar S Dhar S Ghosh S Kaur

2017

3. Thirion L, Nikkels AF, Piérard GE. Etoricoxib-induced erythemamultiforme-like eruption. Dermatology. 2008;216:227--8. 4. Kreft B, Wohlrab J, Bramsiepe I, Eismann R, Winkler M, Marsch WC. Etoricoxib-induced toxic epidermal necrolysis: successful treatment with infliximab. J Dermatol. 2010;37:904--6. 5. Augustine M, Sharma P, Stephen J, Jayaseelan E. Fixed drug eruption and generalised erythem...

Journal: :JAMA dermatology 2014
Francisco A Kerdel Andrew Richard Styperek Archana Maini

Report of a Case A white male patient in his 60s developed pruritic and painful plaques over his upper body. His medical history included Wegner granulomatosis, which was successfully treated with cyclophosphamide in 2006. He took no medications daily and denied any drug allergies. A drug-related cutaneous eruption was considered at the initial evaluation, and sequential courses of corticostero...

2017
Manisha Jakkidi Carine Basmadjian Satyajeet Roy

Acute generalised exanthematous pustulosis (AGEP) is a rare cutaneous eruption, most often caused by commonly used antibiotics. It is characterised by an acute onset of non-follicular sterile pustular rash and erythema within hours or days of drug exposure and usually resolves spontaneously within 1-2 weeks once the drug is discontinued. Haemodynamic involvement in the form of shock is rare. He...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید